Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Nitroglycerin"" wg kryterium: Temat


Starter badań:

Tytuł :
The efficacy of esmolol, remifentanil and nitroglycerin in controlled hypotension for functional endoscopic sinus surgery.
Autorzy :
Alkan A; Muğla Sıtkı Koçman University Education and Research Hospital, Department of Anesthesiology and Reanimation, Muğla, Turkey.
Honca M; Yozgat Bozok University School of Medicine, Department of Anesthesiology and Reanimation, Yozgat, Turkey.
Alkan A; Muğla Sıtkı Koçman University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Muğla, Turkey. Electronic address: .
Güleç H; Ankara Yıldırım Beyazıt University, School of Medicine, Department of Anesthesiology and Reanimation, Ankara, Turkey.
Horasanlı E; Ankara Yıldırım Beyazıt University, School of Medicine, Department of Anesthesiology and Reanimation, Ankara, Turkey.
Pokaż więcej
Źródło :
Brazilian journal of otorhinolaryngology [Braz J Otorhinolaryngol] 2021 May-Jun; Vol. 87 (3), pp. 255-259. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Hypotension, Controlled*
Nitroglycerin*
Cohort Studies ; Humans ; Propanolamines ; Remifentanil
Czasopismo naukowe
Tytuł :
Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives.
Autorzy :
Akerman S; Department of Neural and Pain Sciences, University of Maryland Baltimore, Baltimore, MD, United States.
Romero-Reyes M; Department of Neural and Pain Sciences, University of Maryland Baltimore, Baltimore, MD, United States.
Karsan N; Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom.; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom.
Bose P; Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom.; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom.
Hoffmann JR; Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom.; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom.
Holland PR; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom.
Goadsby PJ; Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom.; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom.; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, United Kingdom.
Pokaż więcej
Źródło :
Pain [Pain] 2021 May 01; Vol. 162 (5), pp. 1567-1577.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Migraine Disorders*/drug therapy
Nitroglycerin*/toxicity
Animals ; Headache ; Hyperalgesia ; Neurons ; Rats
Czasopismo naukowe
Tytuł :
Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study.
Autorzy :
Lawall H; Gemeinschaftspraxis Diehm/Lawall, Ettlingen, Germany. Electronic address: .
Bramlage P; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Gorath M; G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany.
Wittig T; G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany.
Pokaż więcej
Źródło :
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2021 Mar; Vol. 61 (3), pp. 457-465. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Ambulatory Care*
Exercise Tolerance/*drug effects
Intermittent Claudication/*drug therapy
Nitroglycerin/*administration & dosage
Peripheral Arterial Disease/*drug therapy
Vasodilator Agents/*administration & dosage
Administration, Sublingual ; Adult ; Aged ; Aged, 80 and over ; Double-Blind Method ; Drug Administration Schedule ; Female ; Germany ; Humans ; Intermittent Claudication/diagnosis ; Intermittent Claudication/physiopathology ; Male ; Middle Aged ; Nitroglycerin/adverse effects ; Outpatients ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/physiopathology ; Powders ; Proof of Concept Study ; Recovery of Function ; Time Factors ; Treatment Outcome ; Vasodilator Agents/adverse effects
Czasopismo naukowe
Tytuł :
Nitroglycerin patch use in digital ischemia secondary to sepsis: a case report.
Autorzy :
Jadhav DV; Neonatal Intensive Care Unit, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.
Mendonca D; Pediatric Plastic Surgery, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.
Kotinatot S; Neonatal Intensive Care Unit, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.
Shankar S; Neonatal Intensive Care Unit, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.
Mazmi MA; Neonatal Intensive Care Unit, Al Jalila Children´s Specialty Hospital, Dubai, United Arab Emirates.
Pokaż więcej
Źródło :
The Pan African medical journal [Pan Afr Med J] 2021 Feb 03; Vol. 38, pp. 114. Date of Electronic Publication: 2021 Feb 03 (Print Publication: 2021).
Typ publikacji :
Case Reports
MeSH Terms :
Ischemia/*drug therapy
Neonatal Sepsis/*complications
Nitroglycerin/*administration & dosage
Administration, Cutaneous ; Fingers/blood supply ; Gangrene/etiology ; Gangrene/prevention & control ; Humans ; Infant, Newborn ; Ischemia/etiology ; Male ; Nitroglycerin/adverse effects ; Transdermal Patch ; Treatment Outcome ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects
Raport
Tytuł :
Topical nitroglycerin ointment as salvage therapy for peripheral tissue ischemia in newborns: a systematic review.
Autorzy :
Sushko K; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont. .
Litalien C; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Ferruccio L; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Gilpin A; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Mazer-Amirshahi M; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Chan AK; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
van den Anker J; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Lacaze-Masmonteil T; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Samiee-Zafarghandy S; School of Nursing (Sushko), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of General Pediatrics (Litalien), Department of Pediatrics, and the Rosalind & Morris Goodman Family Pediatric Formulations Centre, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Pharmacy (Ferruccio), Hamilton Health Sciences, Hamilton, Ont.; Rosalind & Morris Goodman Family Pediatric Formulations Centre (Gilpin), Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC; Division of Pediatric Hematology/Oncology (Chan), McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children's National Hospital, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University Children's Hospital, University of Basel, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.
Pokaż więcej
Źródło :
CMAJ open [CMAJ Open] 2021 Mar 17; Vol. 9 (1), pp. E252-E260. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Salvage Therapy*
Ischemia/*drug therapy
Nitroglycerin/*therapeutic use
Vasodilator Agents/*therapeutic use
Administration, Cutaneous ; Catheterization, Peripheral/adverse effects ; Humans ; Infant, Newborn ; Intensive Care Units, Neonatal ; Ischemia/etiology ; Nitroglycerin/supply & distribution ; Ointments/supply & distribution ; Vasodilator Agents/supply & distribution
Czasopismo naukowe
Tytuł :
Presence of the aldehyde dehydrogenase 2 variant ALDH2*2 considerably increases EC 50 of nitroglycerin.
Autorzy :
Ushijima K; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, 329-0498, Japan. .; Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Yamaguchi, Japan. .
Ogami C; Department of Medical Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Tsuji Y; School of Pharmacy, Nihon University, Chiba, Japan.
Nagano T; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, 329-0498, Japan.; Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Tochigi, Japan.
Fujimura A; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, 329-0498, Japan.
Pokaż więcej
Źródło :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2021 Mar; Vol. 77 (3), pp. 431-433. Date of Electronic Publication: 2020 Oct 10.
Typ publikacji :
Letter
MeSH Terms :
Pharmacogenomic Variants*
Polymorphism, Genetic*
Aldehyde Dehydrogenase, Mitochondrial/*genetics
Nitroglycerin/*pharmacokinetics
Vasodilation/*drug effects
Vasodilator Agents/*pharmacokinetics
Aldehyde Dehydrogenase, Mitochondrial/metabolism ; Biological Variation, Population ; Dose-Response Relationship, Drug ; Humans ; Nitroglycerin/administration & dosage ; Pharmacogenetics ; Vasodilator Agents/administration & dosage
Opinia redakcyjna
Tytuł :
Are These Pills Made for Walking?
Autorzy :
Nordanstig J; Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: .
Langenskiöld M; Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło :
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2021 Mar; Vol. 61 (3), pp. 466. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Nitroglycerin*
Peripheral Arterial Disease*
Humans ; Outpatients ; Powders ; Proof of Concept Study ; Walking
Czasopismo naukowe
Tytuł :
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
Autorzy :
Daxon BT; From the Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Lark E; Department of Emergency Medicine, Henry Ford Wyandotte Hospital, Wyandotte, Michigan.
Matzek LJ; From the Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Fields AR; From the Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Haselton KJ; From the Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
A&A practice [A A Pract] 2021 Feb 05; Vol. 15 (2), pp. e01376. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Nebulizers and Vaporizers*
COVID-19/*drug therapy
Nitroglycerin/*administration & dosage
Respiratory Distress Syndrome/*drug therapy
Vasodilator Agents/*administration & dosage
COVID-19/complications ; COVID-19/diagnosis ; Humans ; Male ; Middle Aged ; Nitroglycerin/chemical synthesis ; Respiratory Distress Syndrome/diagnosis ; Respiratory Distress Syndrome/etiology
Czasopismo naukowe
Tytuł :
Vasodilation by Verapamil-Nitroglycerin Solution in Microvascular Surgery.
Autorzy :
Seth R; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Badran KW; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.; Department of Otolaryngology-Head and Neck Surgery, University of California-Los Angeles, Los Angeles, California, USA.
Cedars E; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Plonowska K; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Benjamin T; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Saggi S; Department of Otolaryngology-Head and Neck Surgery, University of California-Los Angeles, Los Angeles, California, USA.
Knott PD; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Heaton CM; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
Blackwell KE; Department of Otolaryngology-Head and Neck Surgery, University of California-Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2021 Jan; Vol. 164 (1), pp. 104-109. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Microsurgery*
Vascular Surgical Procedures*
Head and Neck Neoplasms/*surgery
Nitroglycerin/*pharmacology
Surgical Flaps/*blood supply
Vasodilation/*drug effects
Verapamil/*pharmacology
Administration, Topical ; Graft Rejection ; Humans ; Nitroglycerin/administration & dosage ; Papaverine/pharmacology ; Retrospective Studies ; Solutions ; Verapamil/administration & dosage
Czasopismo naukowe
Tytuł :
A comparative study of transdermal nitroglycerine patch and oral nifedipine in preterm labor.
Autorzy :
Kaur P; Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India.
Madan A; Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India.
Sharma S; Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India.
Pokaż więcej
Źródło :
Annals of African medicine [Ann Afr Med] 2021 Jan-Mar; Vol. 20 (1), pp. 31-36.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Nifedipine/*administration & dosage
Nitroglycerin/*administration & dosage
Obstetric Labor, Premature/*prevention & control
Premature Birth/*prevention & control
Tocolysis/*methods
Tocolytic Agents/*administration & dosage
Tocolytic Agents/*therapeutic use
Uterine Contraction/*drug effects
Administration, Cutaneous ; Administration, Oral ; Adult ; Female ; Gestational Age ; Humans ; Nifedipine/adverse effects ; Nifedipine/therapeutic use ; Nitroglycerin/adverse effects ; Nitroglycerin/therapeutic use ; Obstetric Labor, Premature/drug therapy ; Pregnancy ; Pregnancy Outcome ; Tocolytic Agents/adverse effects ; Treatment Outcome ; Uterine Contraction/physiology
Czasopismo naukowe
Tytuł :
Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up.
Autorzy :
Tajdini M; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Aminorroaya A; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Universal Scientific Education and Research Network, Tehran, Iran.
Rahimi B; Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran.
Mortazavi SH; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Vasheghani Farahani A; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Sadeghian S; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Easapour Moghadam M; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Soltani D; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Bozorgi A; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło :
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing [J Interv Card Electrophysiol] 2021 Jan; Vol. 60 (1), pp. 31-39. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Adenosine*
Nitroglycerin*
Syncope, Vasovagal*/diagnosis
Female ; Follow-Up Studies ; Humans ; Male ; Prospective Studies ; Syncope ; Tilt-Table Test
Czasopismo naukowe
Tytuł :
The Use of Topical Nitroglycerin to Facilitate Radial Arterial Catheter Insertion in Children: A Randomized Controlled Trial.
Autorzy :
Hasanin A; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Aboelela A; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Mostafa M; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt. Electronic address: .
Mansour RM; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Kareem A; Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło :
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2020 Dec; Vol. 34 (12), pp. 3354-3360. Date of Electronic Publication: 2020 Apr 29.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Catheterization, Peripheral*
Nitroglycerin*
Catheters ; Child ; Child, Preschool ; Humans ; Punctures ; Radial Artery/diagnostic imaging
Czasopismo naukowe
Tytuł :
Investigation on adsorption features of nitroglycerin on novel red tricycle arsenene nanosheet - A first-principles study.
Autorzy :
Princy Maria J; School of Electrical & Electronics Engineering, SASTRA Deemed University, Tirumalaisamudram, Thanjavur, 613 401, India.
Nagarajan V; School of Electrical & Electronics Engineering, SASTRA Deemed University, Tirumalaisamudram, Thanjavur, 613 401, India.
Chandiramouli R; School of Electrical & Electronics Engineering, SASTRA Deemed University, Tirumalaisamudram, Thanjavur, 613 401, India. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular graphics & modelling [J Mol Graph Model] 2020 Nov; Vol. 100, pp. 107653. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arsenic*
Nitroglycerin*
Adsorption ; Gases
Czasopismo naukowe
Tytuł :
Feasibility, Effectiveness and Safety of Prehospital Intravenous Bolus Dose Nitroglycerin in Patients with Acute Pulmonary Edema.
Autorzy :
Patrick C
Ward B
Anderson J
Rogers Keene K
Adams E
Cash RE
Panchal AR
Dickson R
Pokaż więcej
Źródło :
Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors [Prehosp Emerg Care] 2020 Nov-Dec; Vol. 24 (6), pp. 844-850. Date of Electronic Publication: 2020 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Emergency Medical Services*
Pulmonary Edema*/drug therapy
Nitroglycerin/*administration & dosage
Vasodilator Agents/*administration & dosage
Feasibility Studies ; Humans ; Nitroglycerin/adverse effects ; Retrospective Studies ; Texas ; Vasodilator Agents/adverse effects
Czasopismo naukowe
Tytuł :
Calcitonin gene‑related peptide‑mediated pharmacological effects in cardiovascular and gastrointestinal diseases (Review).
Autorzy :
Ma WJ; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Yin YC; Department of Pharmacy, Shaoyang Central Hospital, Shaoyang, Hunan 422000, P.R. China.
Zhang BK; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Li YJ; Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410078, P.R. China.
Li WQ; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Pokaż więcej
Źródło :
Molecular medicine reports [Mol Med Rep] 2021 Jan; Vol. 23 (1). Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Calcitonin Gene-Related Peptide/*metabolism
Cardiovascular Diseases/*metabolism
Gastrointestinal Diseases/*metabolism
Indole Alkaloids/*pharmacology
Nitroglycerin/*pharmacology
Quinazolines/*pharmacology
Cardiovascular Diseases/drug therapy ; Gastrointestinal Diseases/drug therapy ; Gene Expression Regulation/drug effects ; Humans ; Indole Alkaloids/therapeutic use ; Molecular Targeted Therapy ; Nitroglycerin/therapeutic use ; Quinazolines/therapeutic use ; Up-Regulation
Czasopismo naukowe
Tytuł :
Drug Treatment of Raynaud's Phenomenon of the Nipple.
Autorzy :
Anderson PO; Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, San Diego, California, USA.
Pokaż więcej
Źródło :
Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine [Breastfeed Med] 2020 Nov; Vol. 15 (11), pp. 686-688. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Nipples*
Breast Diseases/*drug therapy
Calcium Channel Blockers/*therapeutic use
Nifedipine/*therapeutic use
Nitroglycerin/*administration & dosage
Phosphodiesterase 5 Inhibitors/*therapeutic use
Raynaud Disease/*drug therapy
Breast Diseases/diagnosis ; Breast Feeding ; Calcium Channel Blockers/administration & dosage ; Female ; Humans ; Nifedipine/administration & dosage ; Nitroglycerin/therapeutic use ; Phosphodiesterase 5 Inhibitors/administration & dosage ; Raynaud Disease/diagnosis
Czasopismo naukowe
Tytuł :
High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series.
Autorzy :
Stemple K; Department of Pharmacy, The University of Vermont Medical Center, United States of America. Electronic address: .
DeWitt KM; Department of Pharmacy, The University of Vermont Medical Center, United States of America.
Porter BA; Department of Pharmacy, The University of Vermont Medical Center, United States of America.
Sheeser M; Department of Surgery, Division of Emergency Medicine, The University of Vermont Medical Center, United States of America.
Blohm E; Department of Surgery, Division of Emergency Medicine, The University of Vermont Medical Center, United States of America.
Bisanzo M; Department of Surgery, Division of Emergency Medicine, The University of Vermont Medical Center, United States of America.
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2021 Jun; Vol. 44, pp. 262-266. Date of Electronic Publication: 2020 Apr 02.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Heart Failure/*drug therapy
Nitroglycerin/*administration & dosage
Pulmonary Edema/*drug therapy
Vasodilator Agents/*administration & dosage
Acute Disease ; Aged ; Female ; Heart Failure/complications ; Heart Failure/diagnosis ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Pulmonary Edema/diagnosis ; Pulmonary Edema/etiology ; Syndrome
Czasopismo naukowe
Tytuł :
The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report.
Autorzy :
Takakura S; Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Tanaka H; Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Enomoto N; Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Maki S; Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Ikeda T; Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Pokaż więcej
Źródło :
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 May 12; Vol. 57 (5). Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Case Reports
MeSH Terms :
Dinoprostone*
Oxytocics*/therapeutic use
Cesarean Section ; Delayed-Action Preparations ; Female ; Heart Rate, Fetal ; Humans ; Labor, Induced ; Nitroglycerin/therapeutic use ; Pregnancy
Raport
Tytuł :
Topical nitroglycerin is associated with a reduced mastectomy skin flap necrosis-systematic review and meta-analysis.
Autorzy :
Vania R; Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Department of Plastic Surgery, Gatot Subroto Army Central Hospital, Jakarta, Indonesia. Electronic address: .
Pranata R; Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia. Electronic address: .
Irwansyah D; Department of Plastic Surgery, Gatot Subroto Army Central Hospital, Jakarta, Indonesia; Faculty of Medicine, Syiah Kuala University, Banda Aceh, Indonesia. Electronic address: .
Budiman; Department of Plastic Surgery, Gatot Subroto Army Central Hospital, Jakarta, Indonesia; Faculty of Medicine, Syiah Kuala University, Banda Aceh, Indonesia. Electronic address: .
Pokaż więcej
Źródło :
Journal of plastic, reconstructive & aesthetic surgery : JPRAS [J Plast Reconstr Aesthet Surg] 2020 Jun; Vol. 73 (6), pp. 1050-1059. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Mastectomy/*adverse effects
Nitroglycerin/*therapeutic use
Skin Transplantation/*adverse effects
Surgical Flaps/*pathology
Vasodilator Agents/*therapeutic use
Administration, Cutaneous ; Female ; Humans ; Mastectomy/methods ; Necrosis ; Nitroglycerin/administration & dosage ; Skin Transplantation/methods ; Surgical Flaps/adverse effects ; Surgical Flaps/blood supply ; Vasodilator Agents/administration & dosage
Czasopismo naukowe
Tytuł :
Cardiovascular magnetic resonance image analysis and mechanism study for the changes after treatments for primary microvascular angina pectoris.
Autorzy :
Huang Q; Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine (HangZhou Red Cross Hospital), Hangzhou, Zhejiang, China.
Wang WT
Wang SS
Pei A
Sui XQ
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 May 28; Vol. 100 (21), pp. e26038.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Coronary Angiography*
Magnetic Resonance Imaging*
Cardiovascular System/*diagnostic imaging
Microvascular Angina/*diagnosis
Vasodilator Agents/*administration & dosage
Adolescent ; Adult ; Aged ; Aspirin/administration & dosage ; Cardiovascular System/drug effects ; Diltiazem/administration & dosage ; Drug Therapy, Combination/methods ; Electrocardiography ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Male ; Microvascular Angina/drug therapy ; Middle Aged ; Nicorandil/administration & dosage ; Nitroglycerin/administration & dosage ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies